Literature DB >> 1093871

Narciclasine: an antitumour alkaloid which blocks peptide bond formation by eukaryotic ribosomes.

L Carrasco, M Fresno, D Vazquez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1093871     DOI： 10.1016/0014-5793(75)80813-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN： 0014-5793            Impact factor:   4.124


× No keyword cloud information.
  15 in total

1.  Targeting of eEF1A with Amaryllidaceae isocarbostyrils as a strategy to combat melanomas.

Authors:  Gwendoline Van Goietsenoven; Jenna Hutton; Jean-Paul Becker; Benjamin Lallemand; Francis Robert; Florence Lefranc; Christine Pirker; Guy Vandenbussche; Pierre Van Antwerpen; Antonio Evidente; Walter Berger; Martine Prévost; Jerry Pelletier; Robert Kiss; Terri Goss Kinzy; Alexander Kornienko; Véronique Mathieu
Journal:  FASEB J       Date:  2010-07-19       Impact factor: 5.191

Review 2.  Chemistry, biology, and medicinal potential of narciclasine and its congeners.

Authors:  Alexander Kornienko; Antonio Evidente
Journal:  Chem Rev       Date:  2008-05-20       Impact factor: 60.622

3.  Inhibition of root growth by narciclasine is caused by DNA damage-induced cell cycle arrest in lettuce seedlings.

Authors:  Yanfeng Hu; Jiaolong Li; Lijing Yang; Wenbin Nan; Xiaoping Cao; Yurong Bi
Journal:  Protoplasma       Date:  2014-01-31       Impact factor: 3.356

4.  Enantioselective Synthesis of Isocarbostyril Alkaloids and Analogs Using Catalytic Dearomative Functionalization of Benzene.

Authors:  Tanner W Bingham; Lucas W Hernandez; Daniel G Olson; Riley L Svec; Paul J Hergenrother; David Sarlah
Journal:  J Am Chem Soc       Date:  2018-12-20       Impact factor: 15.419

5.  TOTAL SYNTHESES OF PANCRATISTATIN. A REVIEW.

Authors:  Madhuri Manpadi; Alexander Kornienko
Journal:  Org Prep Proced Int       Date:  2009-02-18       Impact factor: 1.628

6.  Biological evaluation of structurally diverse amaryllidaceae alkaloids and their synthetic derivatives: discovery of novel leads for anticancer drug design.

Authors:  Antonio Evidente; Artem S Kireev; Aaron R Jenkins; Anntherese E Romero; Wim F A Steelant; Severine Van Slambrouck; Alexander Kornienko
Journal:  Planta Med       Date:  2009-02-23       Impact factor: 3.352

Review 7.  Antibiotics and compounds affecting tanslation by eukaryotic ribosomes. Specific enhancement of aminoacyl-tRNA binding by methylaxnthines.

Authors:  L Carrasco; C Fernandez-Puentes; D Vazquez
Journal:  Mol Cell Biochem       Date:  1976-02-16       Impact factor: 3.396

8.  23S ribosomal RNA mutations in halobacteria conferring resistance to the anti-80S ribosome targeted antibiotic anisomycin.

Authors:  H Hummel; A Böck
Journal:  Nucleic Acids Res       Date:  1987-03-25       Impact factor: 16.971

9.  Structural basis for the inhibition of the eukaryotic ribosome.

Authors:  Nicolas Garreau de Loubresse; Irina Prokhorova; Wolf Holtkamp; Marina V Rodnina; Gulnara Yusupova; Marat Yusupov
Journal:  Nature       Date:  2014-09-10       Impact factor: 49.962

10.  Transcriptomic analysis reveals key early events of narciclasine signaling in Arabidopsis root apex.

Authors:  Xiaoning Cao; Fei Ma; Tingting Xu; Junjie Wang; Sichen Liu; Gaihong Li; Qian Su; Zhijun Qiao; XiaoFan Na
Journal:  Plant Cell Rep       Date:  2016-08-25       Impact factor: 4.570
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.